Author:
Publisher: DIANE Publishing
ISBN: 1428949933
Category :
Languages : en
Pages : 39
Book Description
VA drug formulary better oversight is required, but veterans are getting needed drugs : report to the Ranking Member, Committee on Veterans' Affairs, U.S. Senate
Author:
Publisher: DIANE Publishing
ISBN: 1428949933
Category :
Languages : en
Pages : 39
Book Description
Publisher: DIANE Publishing
ISBN: 1428949933
Category :
Languages : en
Pages : 39
Book Description
VA Drug Formulary
Author: United States. General Accounting Office
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 42
Book Description
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 42
Book Description
Is the U.S Department of Veterans Affairs Meeting the Pharmaceutical Needs of Veterans?
Author: United States. Congress. House. Committee on Veterans' Affairs. Subcommittee on Health
Publisher:
ISBN:
Category : History
Languages : en
Pages : 86
Book Description
Publisher:
ISBN:
Category : History
Languages : en
Pages : 86
Book Description
Congressional Record
Author: United States. Congress
Publisher:
ISBN:
Category : Law
Languages : en
Pages : 1328
Book Description
Publisher:
ISBN:
Category : Law
Languages : en
Pages : 1328
Book Description
Monthly Catalog of United States Government Publications
Author:
Publisher:
ISBN:
Category : Government publications
Languages : en
Pages : 1734
Book Description
Publisher:
ISBN:
Category : Government publications
Languages : en
Pages : 1734
Book Description
Monthly Catalogue, United States Public Documents
Author:
Publisher:
ISBN:
Category : Government publications
Languages : en
Pages : 752
Book Description
Publisher:
ISBN:
Category : Government publications
Languages : en
Pages : 752
Book Description
The Pig Book
Author: Citizens Against Government Waste
Publisher: Macmillan
ISBN: 9780312343576
Category : Business & Economics
Languages : en
Pages : 212
Book Description
A compendium of the most ridiculous examples of Congress's pork-barrel spending.
Publisher: Macmillan
ISBN: 9780312343576
Category : Business & Economics
Languages : en
Pages : 212
Book Description
A compendium of the most ridiculous examples of Congress's pork-barrel spending.
Returning Home from Iraq and Afghanistan
Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309152852
Category : Medical
Languages : en
Pages : 193
Book Description
Nearly 1.9 million U.S. troops have been deployed to Afghanistan and Iraq since October 2001. Many service members and veterans face serious challenges in readjusting to normal life after returning home. This initial book presents findings on the most critical challenges, and lays out the blueprint for the second phase of the study to determine how best to meet the needs of returning troops and their families.
Publisher: National Academies Press
ISBN: 0309152852
Category : Medical
Languages : en
Pages : 193
Book Description
Nearly 1.9 million U.S. troops have been deployed to Afghanistan and Iraq since October 2001. Many service members and veterans face serious challenges in readjusting to normal life after returning home. This initial book presents findings on the most critical challenges, and lays out the blueprint for the second phase of the study to determine how best to meet the needs of returning troops and their families.
VA Opioid Prescription Policy, Practice, and Procedures
Author: United States. Congress. Senate. Committee on Veterans' Affairs
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 109
Book Description
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 109
Book Description
Pain Management and the Opioid Epidemic
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309459540
Category : Medical
Languages : en
Pages : 483
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Publisher: National Academies Press
ISBN: 0309459540
Category : Medical
Languages : en
Pages : 483
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.